Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peroxisomal disorders.

H W Moser1

  • 1Department of Neurogenetics, Kennedy Institute, Baltimore, MD 21205.

Clinical Biochemistry
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Peroxisomal disorders are more common and diverse than previously thought. Advances in biochemical assays and prenatal diagnosis offer new genetic counseling options for these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.

Journal of inherited metabolic disease·2009
Same author

Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy.

Neurology·2005
Same author

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Neurology·2005
Same author

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Neurology·2003
Same author

Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment.

Journal of neurology, neurosurgery, and psychiatry·2003
Same author

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

Neurology·2003
Same journal

Evaluation of hemoglobin interference thresholds for chemical urinalysis panels.

Clinical biochemistry·2026
Same journal

Integrated genomic and biochemical diagnosis of a novel homozygous start-loss variant in AKR1D1 associated with neonatal cholestasis.

Clinical biochemistry·2026
Same journal

Agreement between POC glucose meters and blood gas analyzers varies across ICU patient populations.

Clinical biochemistry·2026
Same journal

From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
Same journal

Response to the letter to the editor: From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
Same journal

What are the correlates of laboratory productivity in clinical laboratories in the Asia Pacific region?

Clinical biochemistry·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Peroxisomal disorders are increasingly recognized as frequent and clinically diverse conditions.
  • Recent research has significantly advanced understanding of peroxisome biogenesis and function.
  • Human disease states have been instrumental in driving these research advancements.

Purpose of the Study:

  • To review recent clinical and research advances in peroxisomal disorders.
  • To highlight the relevance of these disorders for clinical biochemists.
  • To underscore the diagnostic and counseling opportunities presented by these conditions.

Main Methods:

  • Review of current literature on peroxisomal disorders.
  • Analysis of biochemical assays for diagnosis.

Related Experiment Videos

  • Discussion of prenatal diagnostic capabilities.
  • Evaluation of therapeutic strategies for specific disorders like adrenoleukodystrophy.

    • Main Results:

    • Peroxisomal disorders exhibit a broader spectrum of clinical presentations than previously understood.
    • Non-invasive biochemical assays enable precise diagnosis.
    • Prenatal diagnosis is feasible for all peroxisomal disorders, facilitating genetic counseling.
    • Therapeutic interventions are under development for certain conditions.

    Conclusions:

    • Clinical biochemists should be aware of the expanding landscape of peroxisomal disorders.
    • Improved diagnostic tools and prenatal testing enhance patient management and family planning.
    • Ongoing research into peroxisome biology, spurred by disease studies, promises future therapeutic breakthroughs.